Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Shares Outstanding (2023 - 2025)

Incannex Healthcare's Shares Outstanding history spans 3 years, with the latest figure at $359.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 1919.76% year-over-year to $359.2 million; the TTM value through Dec 2025 reached $359.2 million, up 1919.76%, while the annual FY2025 figure was $194.4 million, 1001.75% up from the prior year.
  • Shares Outstanding for Q4 2025 was $359.2 million at Incannex Healthcare, up from $347.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $359.2 million in Q4 2025 and bottomed at $15.9 million in Q3 2023.
  • The 3-year median for Shares Outstanding is $17.7 million (2024), against an average of $103.0 million.
  • The largest annual shift saw Shares Outstanding rose 11.15% in 2024 before it soared 1919.76% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $15.9 million in 2023, then rose by 12.05% to $17.8 million in 2024, then skyrocketed by 1919.76% to $359.2 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Shares Outstanding are $359.2 million (Q4 2025), $347.7 million (Q3 2025), and $194.4 million (Q2 2025).